In prostate cancer, staining of tissue biopsies collected at different stages of the disease has shown that while gal-1 was upregulated in more advanced lesions, gal-3 and gal-9 expression gradually decreased as cancer evolves. This evidence concerns the gene LGALS9 and cancer.